TB-Q Comprehensive Real-Time PCR Kit

Detection of MTB + Drug Resistance Markers for Comprehensive Tuberculosis Testing

The TB-Q Comprehensive Real-Time PCR Kit is a CE-IVD molecular diagnostic assay designed for the simultaneous detection of Mycobacterium tuberculosis (MTB) and associated drug resistance markers in clinical samples.

This assay enables rapid identification of tuberculosis infection along with resistance profiling, supporting timely treatment decisions and improved patient management through a multiplex real-time PCR workflow.

Product Overview


The TB-Q Comprehensive Real-Time PCR Kit is an in vitro diagnostic (IVD) test based on real-time PCR technology for qualitative detection of:

Why Comprehensive TB Testing Matters


Tuberculosis remains a major global infectious disease burden. However, rising drug-resistant TB (DR-TB) cases complicate treatment.

Key clinical concerns:
  • MDR-TB → resistant to Rifampicin + Isoniazid
  • XDR-TB → resistant to first-line + second-line drugs
Comprehensive molecular testing enables:
  • early MTB detection
  • rapid resistance screening
  • targeted therapy selection
  • reduced transmission risk
  • improved treatment outcomes

Targets Detected


MTB Pathogen Targets
  • IS6110
  • MPt64
Drug Resistance Targets

Rifampicin resistance (rpoB gene):

  • Rif-1
  • Rif-2
  • Rif-3
  • Rif-4

Isoniazid resistance:

  • katG
  • inhA
Internal Control
  • RNaseP gene
    Ensures extraction quality and assay validity.

Applications


The kit is ideal for clinical molecular laboratories performing:

TB-Q Comprehensive
  • Comprehensive tuberculosis molecular testing
  • MTB detection
  • MDR-TB screening
  • Drug resistance profiling
  • Infectious disease diagnostics
  • Public health TB surveillance programs TB-Q Comprehensive Real Time PCR

Key Features & Benefits


Comprehensive TB Detection & Resistance Screening

Single assay detects MTB and evaluates drug resistance markers simultaneously.

MDR-TB Risk Identification

Targets mutations associated with resistance to Rifampicin and Isoniazid, the two most critical first-line TB drugs.

Two-Tube Multiplex Assay Design

Ready Mix-1 (RM1): (katG, Rif-2 , Rif-3, IS6110 + MPt64)

Ready Mix-2 (RM2): (Rif-1, Rif-4 , inhA , RNaseP (IC))

Probe-Based Real-Time Detection

High specificity multiplex fluorescence detection for MTB and resistance genes.

Rapid Turnaround for Clinical Decisions

Supports early therapy optimization and infection control measures.

Sample Types & Reporting Output


Sample Types

Validated for use with Sputum samples

  • Sputum samples
Reporting Output

The assay provides integrated qualitative reporting, including:

  • MTB detection status
  • Rifampicin resistance markers
  • Isoniazid resistance markers
  • MDR-TB risk interpretation
  • Ct values & amplification curves
  • Internal control validation
  • Exportable reports via USB / Bluetooth

Compatible System


OnePCR-Rapi-Q Ultra-Fast POC System

Designed for automated workflow including extraction and amplification.

OnePCR® workflow
  • Collect sputum sample
  • Perform liquefaction & inactivation (Buffer IL step)
  • Load 200 µl sample into Cartridge-1
  • Reconstitute RM1 & RM2 tubes
  • Load cartridges / tubes into system
  • Automated extraction + multiplex PCR
  • Results displayed for MTB + resistance markers

Storage & Stability


Ordering Information


Commercial Name Old Cat No. New Cat No. Pack Size
TB-Q Comprehensive Real-Time PCR Kit G2M803121 G610034-3 24 Tests

Why Choose the TB-Q Comprehensive Real-Time PCR Kit?


If your lab requires an advanced tuberculosis PCR kit with drug resistance detection, this assay delivers:

  • MTB detection with dual gene targets
  • Rifampicin + Isoniazid resistance screening
  • MDR-TB risk identification support
  • Multiplex probe-based PCR chemistry
  • Automated extraction-to-result workflow
  • Suitability for high-burden TB testing programs

Product Enquiry Form


Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.


© 2025 Genes2me. All rights reserved.